Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
äŒæ¥ã³ãŒãENOV
äŒç€ŸåEnovis Corp
äžå Žæ¥May 08, 2008
æé«çµå¶è²¬ä»»è
ãCEOãMcdonald (Damien)
åŸæ¥å¡æ°7367
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 08
æ¬ç€Ÿæåšå°2711 Centerville Road
éœåžWILMINGTON
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·19808
é»è©±çªå·13022529160
ãŠã§ããµã€ãhttps://www.enovis.com/
äŒæ¥ã³ãŒãENOV
äžå Žæ¥May 08, 2008
æé«çµå¶è²¬ä»»è
ãCEOãMcdonald (Damien)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã